Article History
Accepted: 6 June 2022
First Online: 30 June 2022
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Bruno Costa and Tarek Mouhieddine declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. Joshua Richter receives consulting fees and fees for serving on a speakers bureau from Amgen; advisory board fees and fees for serving on a speakers bureau from Celgene, Takeda, and Janssen; and advisory board fees from Sanofi, Karyopharm Therapeutics, Oncopeptides, Adaptive Biotechnologies, and Bristol-Myers Squibb.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.